Delivery Order SPE2DB20D1100-SPE2DB25FE5Z5
Award Date 9/11/25
Potential Completion Date 10/2/25
Potential Value $51K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $26,285.93 delivery order to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 300 mg/3 mL vials on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed price contract contains no set-aside designation and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $9,558.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ultomiris 300 mg/3 ml vials. This non-competitive delivery order, with an ultimate completion date of September 29, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $131,429.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 1,100 mg/11 mL vials. This contract, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a non-set-aside competitive award supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $52,571.70 delivery order to AmerisourceBergen Drug Corp for the supply of Ultomiris (1,100 mg/11 mL vials) with an ultimate completion date of September 18, 2025. This firm fixed-price, competitively awarded contract (with no set-aside designation) represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ultomiris (pegtibatimab alfa), a specialty pharmaceutical product, with a ceiling value of $26,285.85. This firm fixed-price delivery order is set to be completed by August 14, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,285.85 to AmerisourceBergen Drug Corp for the supply of Ultomiris 1,100 mg/11 ml vials. This firm fixed-price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of September 16, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger indefinite delivery contract (IDC) vehicle....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,285.93 by the Defense Logistics Agency on July 18, 2025, for the supply of Ultomiris 300 mg/3 ml vials. This competitively awarded, firm fixed-price contract has no set-aside designation and is scheduled for completion by August 8, 2025. The award represents a child delivery order under AmerisourceBergen's broader relationship with the DLA, leveraging the company's established...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,420.20 for Ultomiris 300 mg/3 ml vials on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price, competitively awarded contract (No. 4569318413) is being funded by the Defense Logistics Agency's Medical Supply Chain, a Defense Department entity responsible for pharmaceutical and medical supply...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML. The contract has a ceiling value of $26,285.85 and an ultimate completion date of July 29, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,100 mg/11 ml vials of the pharmaceutical product Ultomiris. The $46,826.19 contract has a completion date of February 27, 2024 and is not set aside for any specific business designation. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a leading global...